The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enterovirus and Parechovirus Testing Market Research Report 2025
Synopsis
Enterovirus is a genus of positive-sense single-stranded RNA viruses associated with several human and mammalian diseases. Enteroviruses are named by their transmission-route through the intestine. Parechovirus is a genus of viruses in the family Picornaviridae. Humans, ferrets, and various rodents serve as natural hosts. The genus currently consists of six accepted species. Human parechoviruses may cause gastrointestinal or respiratory illness in infants, and have been implicated in cases of myocarditis and encephalitis.
The global Enterovirus and Parechovirus Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Enterovirus and Parechovirus Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enterovirus and Parechovirus Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Enterovirus and Parechovirus Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Enterovirus and Parechovirus Testing include Abbexa, Aviva Systems Biology, Creative Diagnostics, CUSABIO Technology, Elitech Group, DiaSorin, Primerdesign, Quidel and BioMerieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enterovirus and Parechovirus Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enterovirus and Parechovirus Testing.
Report Scope
The Enterovirus and Parechovirus Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enterovirus and Parechovirus Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enterovirus and Parechovirus Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbexa
Aviva Systems Biology
Creative Diagnostics
CUSABIO Technology
Elitech Group
DiaSorin
Primerdesign
Quidel
BioMerieux
Cepheid
Segment by Type
RT-PCR
Rapid Test
Segment by Application
Hospitals
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enterovirus and Parechovirus Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Enterovirus is a genus of positive-sense single-stranded RNA viruses associated with several human and mammalian diseases. Enteroviruses are named by their transmission-route through the intestine. Parechovirus is a genus of viruses in the family Picornaviridae. Humans, ferrets, and various rodents serve as natural hosts. The genus currently consists of six accepted species. Human parechoviruses may cause gastrointestinal or respiratory illness in infants, and have been implicated in cases of myocarditis and encephalitis.
The global Enterovirus and Parechovirus Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Enterovirus and Parechovirus Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enterovirus and Parechovirus Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Enterovirus and Parechovirus Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Enterovirus and Parechovirus Testing include Abbexa, Aviva Systems Biology, Creative Diagnostics, CUSABIO Technology, Elitech Group, DiaSorin, Primerdesign, Quidel and BioMerieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enterovirus and Parechovirus Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enterovirus and Parechovirus Testing.
Report Scope
The Enterovirus and Parechovirus Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enterovirus and Parechovirus Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enterovirus and Parechovirus Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbexa
Aviva Systems Biology
Creative Diagnostics
CUSABIO Technology
Elitech Group
DiaSorin
Primerdesign
Quidel
BioMerieux
Cepheid
Segment by Type
RT-PCR
Rapid Test
Segment by Application
Hospitals
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enterovirus and Parechovirus Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enterovirus and Parechovirus Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 RT-PCR
1.2.3 Rapid Test
1.3 Market by Application
1.3.1 Global Enterovirus and Parechovirus Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Enterovirus and Parechovirus Testing Market Perspective (2019-2030)
2.2 Enterovirus and Parechovirus Testing Growth Trends by Region
2.2.1 Global Enterovirus and Parechovirus Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Enterovirus and Parechovirus Testing Historic Market Size by Region (2019-2024)
2.2.3 Enterovirus and Parechovirus Testing Forecasted Market Size by Region (2025-2030)
2.3 Enterovirus and Parechovirus Testing Market Dynamics
2.3.1 Enterovirus and Parechovirus Testing Industry Trends
2.3.2 Enterovirus and Parechovirus Testing Market Drivers
2.3.3 Enterovirus and Parechovirus Testing Market Challenges
2.3.4 Enterovirus and Parechovirus Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Enterovirus and Parechovirus Testing Players by Revenue
3.1.1 Global Top Enterovirus and Parechovirus Testing Players by Revenue (2019-2024)
3.1.2 Global Enterovirus and Parechovirus Testing Revenue Market Share by Players (2019-2024)
3.2 Global Enterovirus and Parechovirus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Enterovirus and Parechovirus Testing Revenue
3.4 Global Enterovirus and Parechovirus Testing Market Concentration Ratio
3.4.1 Global Enterovirus and Parechovirus Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enterovirus and Parechovirus Testing Revenue in 2023
3.5 Enterovirus and Parechovirus Testing Key Players Head office and Area Served
3.6 Key Players Enterovirus and Parechovirus Testing Product Solution and Service
3.7 Date of Enter into Enterovirus and Parechovirus Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Enterovirus and Parechovirus Testing Breakdown Data by Type
4.1 Global Enterovirus and Parechovirus Testing Historic Market Size by Type (2019-2024)
4.2 Global Enterovirus and Parechovirus Testing Forecasted Market Size by Type (2025-2030)
5 Enterovirus and Parechovirus Testing Breakdown Data by Application
5.1 Global Enterovirus and Parechovirus Testing Historic Market Size by Application (2019-2024)
5.2 Global Enterovirus and Parechovirus Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Enterovirus and Parechovirus Testing Market Size (2019-2030)
6.2 North America Enterovirus and Parechovirus Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Enterovirus and Parechovirus Testing Market Size by Country (2019-2024)
6.4 North America Enterovirus and Parechovirus Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Enterovirus and Parechovirus Testing Market Size (2019-2030)
7.2 Europe Enterovirus and Parechovirus Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Enterovirus and Parechovirus Testing Market Size by Country (2019-2024)
7.4 Europe Enterovirus and Parechovirus Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Enterovirus and Parechovirus Testing Market Size (2019-2030)
8.2 Asia-Pacific Enterovirus and Parechovirus Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Enterovirus and Parechovirus Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Enterovirus and Parechovirus Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Enterovirus and Parechovirus Testing Market Size (2019-2030)
9.2 Latin America Enterovirus and Parechovirus Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Enterovirus and Parechovirus Testing Market Size by Country (2019-2024)
9.4 Latin America Enterovirus and Parechovirus Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Enterovirus and Parechovirus Testing Market Size (2019-2030)
10.2 Middle East & Africa Enterovirus and Parechovirus Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Enterovirus and Parechovirus Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Enterovirus and Parechovirus Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbexa
11.1.1 Abbexa Company Detail
11.1.2 Abbexa Business Overview
11.1.3 Abbexa Enterovirus and Parechovirus Testing Introduction
11.1.4 Abbexa Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.1.5 Abbexa Recent Development
11.2 Aviva Systems Biology
11.2.1 Aviva Systems Biology Company Detail
11.2.2 Aviva Systems Biology Business Overview
11.2.3 Aviva Systems Biology Enterovirus and Parechovirus Testing Introduction
11.2.4 Aviva Systems Biology Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.2.5 Aviva Systems Biology Recent Development
11.3 Creative Diagnostics
11.3.1 Creative Diagnostics Company Detail
11.3.2 Creative Diagnostics Business Overview
11.3.3 Creative Diagnostics Enterovirus and Parechovirus Testing Introduction
11.3.4 Creative Diagnostics Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.3.5 Creative Diagnostics Recent Development
11.4 CUSABIO Technology
11.4.1 CUSABIO Technology Company Detail
11.4.2 CUSABIO Technology Business Overview
11.4.3 CUSABIO Technology Enterovirus and Parechovirus Testing Introduction
11.4.4 CUSABIO Technology Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.4.5 CUSABIO Technology Recent Development
11.5 Elitech Group
11.5.1 Elitech Group Company Detail
11.5.2 Elitech Group Business Overview
11.5.3 Elitech Group Enterovirus and Parechovirus Testing Introduction
11.5.4 Elitech Group Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.5.5 Elitech Group Recent Development
11.6 DiaSorin
11.6.1 DiaSorin Company Detail
11.6.2 DiaSorin Business Overview
11.6.3 DiaSorin Enterovirus and Parechovirus Testing Introduction
11.6.4 DiaSorin Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.6.5 DiaSorin Recent Development
11.7 Primerdesign
11.7.1 Primerdesign Company Detail
11.7.2 Primerdesign Business Overview
11.7.3 Primerdesign Enterovirus and Parechovirus Testing Introduction
11.7.4 Primerdesign Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.7.5 Primerdesign Recent Development
11.8 Quidel
11.8.1 Quidel Company Detail
11.8.2 Quidel Business Overview
11.8.3 Quidel Enterovirus and Parechovirus Testing Introduction
11.8.4 Quidel Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.8.5 Quidel Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Detail
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Enterovirus and Parechovirus Testing Introduction
11.9.4 BioMerieux Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.9.5 BioMerieux Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Detail
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Enterovirus and Parechovirus Testing Introduction
11.10.4 Cepheid Revenue in Enterovirus and Parechovirus Testing Business (2019-2024)
11.10.5 Cepheid Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
